scholarly journals Alcohol‐attributed disease burden in four Nordic countries between 2000 and 2017: Are the gender gaps narrowing? A comparison using the Global Burden of Disease, Injury and Risk Factor 2017 study

2020 ◽  
Author(s):  
Emilie E. Agardh ◽  
Peter Allebeck ◽  
Pär Flodin ◽  
Peter Wennberg ◽  
Mats Ramstedt ◽  
...  
Keyword(s):  
Risk Factor ◽  
Burden Of Disease ◽  
Disease Burden ◽  
Nordic Countries ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
Gender Gaps

scholarly journals Alcohol‐attributed disease burden in four Nordic countries: a comparison using the Global Burden of Disease, Injuries and Risk Factors 2013 study

Addiction ◽  
2016 ◽  
Vol 111 (10) ◽  
pp. 1806-1813 ◽  
Author(s):  
Emilie E. Agardh ◽  
Anna‐Karin Danielsson ◽  
Mats Ramstedt ◽  
Astrid Ledgaard Holm ◽  
Finn Diderichsen ◽  
...  
Keyword(s):  
Risk Factors ◽  
Burden Of Disease ◽  
Disease Burden ◽  
Nordic Countries ◽  
Global Burden Of Disease ◽  
Global Burden

scholarly journals Trends in prevalence, mortality and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the “Global Burden of Disease 2017” (GBD2017) study

2020 ◽  
Author(s):  
Bruno Ramos Nascimento ◽  
Luisa Campos Caldeira Brant ◽  
Simon Yadgir ◽  
Gláucia Maria Moraes Oliveira ◽  
Gregory Roth ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Risk Factor ◽  
Systolic Blood Pressure ◽  
Burden Of Disease ◽  
Disease Burden ◽  
Population Aging ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
High Systolic Blood Pressure ◽  
Death Rates

Abstract Background Hypertension remains the leading risk factor for cardiovascular disease (CVD) worldwide, and its impact in Brazil should be assessed in order to better address the issue. We aimed to describe trends in prevalence and burden of disease attributable to high systolic blood pressure (HSBP) among Brazilians ≥ 25 years old according to sex and federal units (FU) using the Global Burden of Disease (GBD) 2017 estimates. Methods We used the comparative risk assessment developed for the GBD study to estimate trends in attributable deaths and disability-adjusted life-years (DALY), by sex, and FU for HSBP from 1990 to 2017. This study included 14 HSBP-outcome pairs. HSBP was defined as ≥ 140 mmHg for prevalence estimates and a theoretical minimum risk exposure level (TMREL) of 110–115 mmHg was considered for disease burden. We estimated the portion of deaths and DALYs attributed to HSBP. We also explored the drivers of trends in HSBP burden, as well as the correlation between disease burden and sociodemographic development index (SDI). Results In Brazil, the prevalence of HSBP is 18.9% (95% uncertainty intervals [UI] 18.5–19.3%), with an annual 0.4% increase rate, while age-standardized death rates attributable to HSBP decreased from 189.2 (95%UI 168.5-209.2) deaths to 104.8 (95%UI 94.9-114.4) deaths per 100,000 from 1990 to 2017. In spite of that, the total number of deaths attributable to HSBP increased 53.4% and HSBP raised from 3rd to 1st position, as the leading risk factor for deaths during the period. Regarding total DALYs, HSBP raised from 4th in 1990 to 2nd cause in 2017. The main driver of change of HSBP burden is population aging. Across FUs, the reduction in the age-standardized death rates attributable to HSBP correlated with higher SDI. Conclusions While HSBP prevalence shows an increasing trend, age-standardized death and DALY rates are decreasing in Brazil, probably as results of successful public policies for CVD secondary prevention and control, but suboptimal control of its determinants. Reduction was more significant in FUs with higher SDI, suggesting that the effect of health policies was heterogeneous. Moreover, HSBP has become the main risk factor for death in Brazil, mainly due to population aging.

scholarly journals Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the “Global Burden of Disease 2017” (GBD 2017) study

2020 ◽  
Vol 18 (S1) ◽  
Author(s):  
Bruno Ramos Nascimento ◽  
Luísa Campos Caldeira Brant ◽  
Simon Yadgir ◽  
Gláucia Maria Moraes Oliveira ◽  
Gregory Roth ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Risk Factor ◽  
Systolic Blood Pressure ◽  
Burden Of Disease ◽  
Disease Burden ◽  
Population Aging ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
High Systolic Blood Pressure ◽  
Death Rates

Abstract Background Hypertension remains the leading risk factor for cardiovascular disease (CVD) worldwide, and its impact in Brazil should be assessed in order to better address the issue. We aimed to describe trends in prevalence and burden of disease attributable to high systolic blood pressure (HSBP) among Brazilians ≥ 25 years old according to sex and federal units (FU) using the Global Burden of Disease (GBD) 2017 estimates. Methods We used the comparative risk assessment developed for the GBD study to estimate trends in attributable deaths and disability-adjusted life-years (DALY), by sex, and FU for HSBP from 1990 to 2017. This study included 14 HSBP-outcome pairs. HSBP was defined as ≥ 140 mmHg for prevalence estimates, and a theoretical minimum risk exposure level (TMREL) of 110–115 mmHg was considered for disease burden. We estimated the portion of deaths and DALYs attributed to HSBP. We also explored the drivers of trends in HSBP burden, as well as the correlation between disease burden and sociodemographic development index (SDI). Results In Brazil, the prevalence of HSBP is 18.9% (95% uncertainty intervals [UI] 18.5–19.3%), with an annual 0.4% increase rate, while age-standardized death rates attributable to HSBP decreased from 189.2 (95%UI 168.5–209.2) deaths to 104.8 (95%UI 94.9–114.4) deaths per 100,000 from 1990 to 2017. In spite of that, the total number of deaths attributable to HSBP increased 53.4% and HSBP raised from 3rd to 1st position, as the leading risk factor for deaths during the period. Regarding total DALYs, HSBP raised from 4th in 1990 to 2nd cause in 2017. The main driver of change of HSBP burden is population aging. Across FUs, the reduction in the age-standardized death rates attributable to HSBP correlated with higher SDI. Conclusions While HSBP prevalence shows an increasing trend, age-standardized death and DALY rates are decreasing in Brazil, probably as results of successful public policies for CVD secondary prevention and control, but suboptimal control of its determinants. Reduction was more significant in FUs with higher SDI, suggesting that the effect of health policies was heterogeneous. Moreover, HSBP has become the main risk factor for death in Brazil, mainly due to population aging.

scholarly journals Completeness and quality of low back pain prevalence data in the Global Burden of Disease Study 2017

2021 ◽  
Vol 6 (5) ◽  
pp. e005847
Author(s):  
Mamata Tamrakar ◽  
Priti Kharel ◽  
Adrian Traeger ◽  
Chris Maher ◽  
Mary O'Keeffe ◽  
...  
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Burden Of Disease ◽  
Disease Burden ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
Low Back ◽  
Prevalence Data ◽  
Pain Prevalence ◽  
Acceptable Measure

IntroductionCompleteness of Global Burden of Disease (GBD) Study data is acknowledged as a limitation. To date, no study has evaluated this issue for low back pain, a leading contributor to disease burden globally.MethodsWe retrieved reports, in any language, based on citation details from the GBD 2017 study website. Pairs of raters independently extracted the following data: number of prevalence reports tallied across countries, age groups, gender and years from 1987 to 2017. We also considered if studies enrolled a representative sample and/or used an acceptable measure of low back pain.ResultsWe retrieved 488 country-level reports that provide prevalence data for 103 of 204 countries (50.5%), with most prevalence reports (61%) being for high-income countries. Only 16 countries (7.8%) have prevalence reports for each of the three decades of the GBD. Most of the reports (79%) did not use an acceptable measure of low back pain when estimating prevalence.ConclusionWe found incomplete coverage across countries and time, and limitations in the primary prevalence studies included in the GBD 2017 study. This means there is considerable uncertainty about GBD estimates of low back pain prevalence and the disease burden metrics derived from prevalence.

scholarly journals The comparative risk assessment for alcohol as part of the Global Burden of Disease 2010 Study: What changed from the last study?

2013 ◽  
Vol 2 (1) ◽  
pp. 1-5 ◽  
Author(s):  
Jürgen Rehm ◽  
Guilherme Borges ◽  
Gerhard Gmel ◽  
Kathryn Graham ◽  
Bridget Grant ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Risk Factor ◽  
Burden Of Disease ◽  
World Health ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
Comparative Risk Assessment ◽  
Comparative Risk ◽  
Health Organization ◽  
Global Population

Rehm, J., Borges, G., Gmel, G., Graham, K., Grant, B., Parry, C., Poznyak, V. & Room R. (2013). The comparative risk assessment for alcohol as part of the Global Burden of Disease 2010 study: What changed from the last study? International Journal of Alcohol and Drug Research, 2(1), 1-5.  doi: 10.7895/ijadr.v2i1.132 (http://dx.doi.org/10.7895/ijadr.v2i1.132)In December 2012, the new results of the Comparative Risk Assessment (CRA) for alcohol within the Global Burden of Disease and Injury (GBD) Study 2010 were presented at a joint meeting of the GBD Group and the journal Lancet at the Royal Society in London (Lim et al., 2012). At first glance, there do not appear to be many changes to alcohol consumption as a risk factor for death and disability: it is identified as the third most important risk factor, as it was in the last CRA (World Health Organization, 2009). The burden of disease attributable to alcohol had increased, compared to the 2004 estimate (Rehm, Mathers et al., 2009), but this could be due to an increase in global population, or to variations in the methodologies behind the 2004 and 2010 estimates.

scholarly journals Diseases due to unhealthy environments: an updated estimate of the global burden of disease attributable to environmental determinants of health

2016 ◽  
Vol 39 (3) ◽  
pp. 464-475 ◽  
Author(s):  
A. Prüss-Ustün ◽  
J. Wolf ◽  
C. Corvalán ◽  
T. Neville ◽  
R. Bos ◽  
...  
Keyword(s):  
Burden Of Disease ◽  
Disease Burden ◽  
Environmental Risks ◽  
Global Burden Of Disease ◽  
Intersectoral Collaboration ◽  
Global Burden ◽  
Potential Health ◽  
Life Years ◽  
Comparative Risk ◽  
Global Disease Burden

Abstract Background The update of the global burden of disease attributable to the environment is presented. The study focuses on modifiable risks to show the potential health impact from environmental interventions. Methods Systematic literature reviews on 133 diseases and injuries were performed. Comparative risk assessments were complemented by more limited epidemiological estimates, expert opinion and information on disease transmission pathways. Population attributable fractions were used to calculate global deaths and global disease burden from environmental risks. Results Twenty-three percent (95% CI: 13–34%) of global deaths and 22% (95% CI: 13–32%) of global disability adjusted life years (DALYs) were attributable to environmental risks in 2012. Sixty-eight percent of deaths and 56% of DALYs could be estimated with comparative risk assessment methods. The global disease burden attributable to the environment is now dominated by noncommunicable diseases. Susceptible ages are children under five and adults between 50 and 75 years. Country level data are presented. Conclusions Nearly a quarter of global disease burden could be prevented by reducing environmental risks. This analysis confirms that eliminating hazards and reducing environmental risks will greatly benefit our health, will contribute to attaining the recently agreed Sustainable Development Goals and will systematically require intersectoral collaboration to be successful.

Sign in / Sign up

Export Citation Format

Share Document